Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M L Orme

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|February 23, 2017
Levosimendan in SepsisAnthony C Gordon, Robert M L Orme, Mervyn Singer
Intensive Care Medicine|August 21, 2019
Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialDavid B Antcliffe, Shalini Santhakumaran, Robert M L Orme, et al.
The New England Journal of Medicine|October 6, 2016
Levosimendan for the Prevention of Acute Organ Dysfunction in SepsisAnthony C Gordon, Gavin D Perkins, Mervyn Singer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|February 23, 2017
Levosimendan in SepsisAnthony C Gordon, Robert M L Orme, Mervyn Singer
Intensive Care Medicine|August 21, 2019
Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialDavid B Antcliffe, Shalini Santhakumaran, Robert M L Orme, et al.
The New England Journal of Medicine|October 6, 2016
Levosimendan for the Prevention of Acute Organ Dysfunction in SepsisAnthony C Gordon, Gavin D Perkins, Mervyn Singer, et al.
Pageof 1